These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 22161274)

  • 1. Cadmium a metalloestrogen: are we convinced?
    Silva N; Peiris-John R; Wickremasinghe R; Senanayake H; Sathiakumar N
    J Appl Toxicol; 2012 May; 32(5):318-32. PubMed ID: 22161274
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Metalloestrogens: an emerging class of inorganic xenoestrogens with potential to add to the oestrogenic burden of the human breast.
    Darbre PD
    J Appl Toxicol; 2006; 26(3):191-7. PubMed ID: 16489580
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metals and breast cancer.
    Byrne C; Divekar SD; Storchan GB; Parodi DA; Martin MB
    J Mammary Gland Biol Neoplasia; 2013 Mar; 18(1):63-73. PubMed ID: 23338949
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The role of cadmium and nickel in estrogen receptor signaling and breast cancer: metalloestrogens or not?
    Aquino NB; Sevigny MB; Sabangan J; Louie MC
    J Environ Sci Health C Environ Carcinog Ecotoxicol Rev; 2012; 30(3):189-224. PubMed ID: 22970719
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Melatonin inhibits both ER alpha activation and breast cancer cell proliferation induced by a metalloestrogen, cadmium.
    Martínez-Campa C; Alonso-González C; Mediavilla MD; Cos S; González A; Ramos S; Sánchez-Barceló EJ
    J Pineal Res; 2006 May; 40(4):291-6. PubMed ID: 16635015
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cofactor competition between the ligand-bound oestrogen receptor and an intron 1 enhancer leads to oestrogen repression of ERBB2 expression in breast cancer.
    Newman SP; Bates NP; Vernimmen D; Parker MG; Hurst HC
    Oncogene; 2000 Jan; 19(4):490-7. PubMed ID: 10698518
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Are cadmium and other heavy metal compounds acting as endocrine disrupters?
    Kortenkamp A
    Met Ions Life Sci; 2011; 8():305-17. PubMed ID: 21473385
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Estrogens, cathepsin D and metastasis in cancers of the breast and ovary: invasion or proliferation?].
    Rochefort H
    C R Seances Soc Biol Fil; 1998; 192(2):241-51. PubMed ID: 9841098
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Endocrine-responsive breast cancer and strategies for combating resistance.
    Ali S; Coombes RC
    Nat Rev Cancer; 2002 Feb; 2(2):101-12. PubMed ID: 12635173
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MAP kinase/estrogen receptor cross-talk enhances estrogen-mediated signaling and tumor growth but does not confer tamoxifen resistance.
    Atanaskova N; Keshamouni VG; Krueger JS; Schwartz JA; Miller F; Reddy KB
    Oncogene; 2002 Jun; 21(25):4000-8. PubMed ID: 12037682
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Estrogens and their receptors in breast cancer progression: a dual role in cancer proliferation and invasion.
    Platet N; Cathiard AM; Gleizes M; Garcia M
    Crit Rev Oncol Hematol; 2004 Jul; 51(1):55-67. PubMed ID: 15207254
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of oestrogen receptor signalling by association with the activated dioxin receptor.
    Ohtake F; Takeyama K; Matsumoto T; Kitagawa H; Yamamoto Y; Nohara K; Tohyama C; Krust A; Mimura J; Chambon P; Yanagisawa J; Fujii-Kuriyama Y; Kato S
    Nature; 2003 May; 423(6939):545-50. PubMed ID: 12774124
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ZIP8, member of the solute-carrier-39 (SLC39) metal-transporter family: characterization of transporter properties.
    He L; Girijashanker K; Dalton TP; Reed J; Li H; Soleimani M; Nebert DW
    Mol Pharmacol; 2006 Jul; 70(1):171-80. PubMed ID: 16638970
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cadmium modulates expression of aryl hydrocarbon receptor-associated genes in rat uterus by interaction with the estrogen receptor.
    Kluxen FM; Höfer N; Kretzschmar G; Degen GH; Diel P
    Arch Toxicol; 2012 Apr; 86(4):591-601. PubMed ID: 22127542
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cadmium--a metallohormone?
    Byrne C; Divekar SD; Storchan GB; Parodi DA; Martin MB
    Toxicol Appl Pharmacol; 2009 Aug; 238(3):266-71. PubMed ID: 19362102
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Estrogen dependent plasminogen activator in breast cancer cells; experimental and clinical studies].
    Yamashita J; Inada K; Matsuo S; Kawano I; Misumi A; Akagi M
    Nihon Geka Gakkai Zasshi; 1989 Nov; 90(11):1932-8. PubMed ID: 2514343
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Plant responses to abiotic stresses: heavy metal-induced oxidative stress and protection by mycorrhization.
    Schützendübel A; Polle A
    J Exp Bot; 2002 May; 53(372):1351-65. PubMed ID: 11997381
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cellular response of human breast cancer to estrogen.
    Wilding G; Lippman ME; Dickson RB
    Prog Clin Biol Res; 1988; 262():181-96. PubMed ID: 3287389
    [No Abstract]   [Full Text] [Related]  

  • 19. Adverse effects of low level heavy metal exposure on male reproductive function.
    Wirth JJ; Mijal RS
    Syst Biol Reprod Med; 2010 Apr; 56(2):147-67. PubMed ID: 20377313
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunomodulatory effects of estradiol and cadmium in adult female rats.
    Pillet S; D'Elia M; Bernier J; Bouquegneau JM; Fournier M; Cyr DG
    Toxicol Sci; 2006 Aug; 92(2):423-32. PubMed ID: 16675514
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.